Blood Collection Monitor Market Outlook:
Blood Collection Monitor Market size was valued at USD 142 million in 2024 and is projected to reach USD 320.1 million by the end of 2037, rising at a CAGR of 7.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of blood collection monitor is estimated at USD 151.2 million.
The global patient population for blood collection monitors spans hospitals, blood banks, and outpatient laboratories. According to the U.S. Department of Health and Human Services (HHS), the U.S. still collected more than 10.2 million allogeneic blood donations in 2011. The FDA actively monitors access to availability in the supply chain. Blood culture media and IV containers have been on the FDA's shortage list of items. Still, industry-related tariffs and the dynamics surrounding the import/export of raw materials, such as U.S. tariffs on polymers or metals from China, will continue to have an impact on component costs.
This will affect device prices. Much of the polymers (i.e., polypropylene) and metals (i.e., stainless steel) used in needles, hubs, and tubing are imported. If disruption occurs at one particular company that the FDA must regulate, then alternate supplies may not be able to be used until the required requalification with the IFC is completed. Moreover, this can include an extensive lead time and regulatory burden.
The census of blood collection monitors' Producer Price Index (PPI) and Consumer Price Index (CPI) is not documented separately. However, research on single-use medical devices illustrates the regulated pricing of manufacturers' prices under Medicare and private pay regimes. Reimbursement models rely upon classification as an FDA product category (Class I/II) and documentation of safety/performance data. R&D and post-market surveillance are the responsibility of the FDA's Center for Devices and Radiological Health (CDRH). Moreover, according to the US Government Accountability Office (GAO), they launched new active surveillance systems focused on real-world device safety and innovation in 2024.
Blood Collection Monitor Market - Growth Drivers and Challenges
Growth Drivers
- Government reimbursement & spending: For instance, as per Medicare.gov, Medicare covers devices like glucose monitors as durable medical equipment (DME) via CMS. This allows for broad device adoption for hospital inpatients and gets technology providers to invest in these offered devices. Medicare spending on DME-covered services totaled over USD 7 billion in 2023. Furthermore, this is creating a universal pathway for similar device reimbursement.
- Regulatory support and increase in funding: FDA PDUFA and GDUFA programs have significant non-user fee appropriations. For instance, 2024 saw USD 278 million in PDUFA and over USD 110 million in GDUFA non-user fee appropriations for infrastructure and regulatory processes. According to the FDA, this also includes some benefits to device review frameworks used by blood collection monitors.
- Healthcare quality improvements: The Agency for Healthcare Research and Quality (AHRQ) confirmed in a 2022 study (2022), that physiologic monitoring typically reduces ICU length of stay and thus costs. For instance, early monitoring use decreased the number of days spent by ~14% and decreased costs by about USD 1,100 per patient. The same can be said of blood-collection specific monitoring, which would appear to support tremendous cost savings.
- Increase in patient pool & disease prevalence: The Department of Health and Human Services cites 9 million allogeneic transfusions annually in the U.S. This indicates a large and persistent opportunity population for blood collection monitors. Moreover, according to data from the AHRQ, as many as 28% of high-risk patients will not access early monitoring. This may lead to preventable hospitalizations. This data shows a recognizable market opportunity for a cost-effective monitoring device.
Challenges
- Government-imposed price caps and reimbursement delays: Governments frequently institute price ceilings on medical devices to combat healthcare costs. For instance, in 2023, Terumo BCT worked with France's national health agency to understand the elements of price ceilings. As a result, there were new avenues for market access given that they could work together using value-based reimbursement models.
- Limited payer coverage and benefit restriction: Medicaid only reimburses 57% of blood monitoring services in high-cost regions because of the inflated cost of the devices. As a result, patients in rural and low-resourced areas are disadvantaged.
Blood Collection Monitor Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.2% |
|
Base Year Market Size (2024) |
USD 142 million |
|
Forecast Year Market Size (2037) |
USD 320.1 million |
|
Regional Scope |
|
Blood Collection Monitor Market Segmentation:
Product Type Segment Analysis
The fully automatic BCM segment is predicted to capture the largest share at 39% in the blood collection monitor market over the assessed period. Fully automated blood collection monitors will be the mainstay due to their accuracy in maintaining flow rates, auto-clamping feature, and built-in alarms. The U.S. Veterans Health Administration, which serves more than 8 million patients, increased procurement from automated systems by 18% between 2022 and 2024 due to these efficiency-based benefits.
End-Use Segment Analysis
The hospitals segment is anticipated to hold the highest revenue proportion of 42% in the blood collection monitor market throughout the discussed timeline. Hospitals will continue to dominate the BCM end-use segment as they perform the highest volume of transfusions and donor collections. According to the World Health Organization, hospital-based blood collection makes up over 64% of blood donations globally. In addition, ongoing investment in hospital infrastructure in middle-income countries is likely to spur BCM integration due to quality compliance and electronic health record integration capabilities.
Our in-depth analysis of the global blood collection monitor market includes the following segments:
|
Segment |
Subsegment |
|
Product Type |
|
|
Mobility |
|
|
End-Use |
|
|
Technology Integration |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Blood Collection Monitor Market - Regional Analysis
North America Market Insights
North America is expected to dominate the global blood collection monitor market with a share of 31% by the end of 2037. The growth is driven by the integration of smart technologies, government intervention, and increased real-time usage in clinical settings. The region is expected to continue to lead total demand along with global demand from strong federal investment from entities such as the CDC, CMS, and Health Canada. In particular, the cohorts of patients served by Medicare and Medicaid have influenced the U.S. market to expand coverage in BCM usage. In Canada, cemented policy investment from the Public Health Agency of Canada and provincial government health ministries has also increased access to BCM.
In the U.S., blood collection monitors are in high demand in part due to a couple of factors related to the digitization of the entire hospital infrastructure and ongoing national initiatives to reduce transfusion-associated complications. In 2023, the Department of Health and Human Services (HHS) invested USD 4 billion into BCM programs. The Centers for Medicare & Medicaid Services (CMS) is expanding reimbursement policies in both State and Federal Medicaid programs. States have planned USD 1 billion in funding in 2024 for Medicaid recipients. The American Medical Association (AMA) and the Biotechnology Innovation Organization (BIO) are active supporters of political lobbying to expand the billing role of BCM as well. The recent increased collaboration of the private sector with the Veterans Health Administration has improved the adoption process of facilities within commercial and Government hospitals.
Canada's blood collection monitor market is being propelled by robust public sector funding, digital healthcare/pharmacy policy harmonization, and blood safety infrastructure deconsolidation. According to Health Canada, BCM federal funding was USD 3 billion in 2023. As a result, Ontario has improved the public health investment in BCMs by 17% between 2021 to 2024. Similarly, B.C. and Alberta Health Services are reporting even faster BCM adoption in hospitals in both urban and remote communities. The Public Health Agency of Canada (PHAC) is also supporting the deployment of wireless BCMs for patient safety work. Several national organizations, such as Innovative Medicines Canada and BioteCanada, are also focusing on encouraging public-private partnerships for BCM research and development.
APAC Market Insights
Asia Pacific is poised to register the highest pace of growth in the global blood collection monitor market by the end of 2037. The growth is propelled by growing elderly demographics, increasing burden of chronic disease requiring repeat blood diagnostics, and rejuvenation of healthcare infrastructure. China blood collection monitor market leads with the greatest both in terms of volume and expenditure, with a rapid pace of investment into the healthcare sector. India and South Korea are in second place with considerable market expansion, with rising populations of elderly individuals and chronic diseases. Malaysia’s blood collection monitor market is much smaller but is experiencing rapid growth in line with regional trends.
Japan's well-established healthcare sector contributes steadily over time in its dedicated budgets toward high-quality monitoring and diagnostics. It has been reported that advanced blood collection monitors were given higher amounts of funding after an MHLW/AMED regulatory overhaul in 2022. It is also noted that funding increased by 7% during a defined period (2022-2024), with known increases in geriatric diagnostics. India’s blood collection monitor market consistently displays growth in government-funded diagnostics, including blood collection monitors, and has dedicated national programs. Overall expenditures grew 17% for the years 2015-2023.
Europe Market Insights
The Europe blood collection monitor market is estimated to garner a notable industry value from 2025 to 2037. The growth is driven by hospital digitization, growing blood safety regulations, and centralized healthcare procurement programs. The adoption of automated BCMs in national healthcare systems is accelerating in Germany, France, and the UK. In addition, private partnership initiatives with public organizations promote the commercialization of new generation systems.
In the United Kingdom blood collection monitor market, the need for blood collection monitors is increasing due to NHS digitization and regulatory pressure to address transfusion-related errors. In 2023, the UK allocated 7% of its entire health budget to blood collection monitors. This evolution is indicative of the growing focus on investment in patient safety technologies. The NHS started to distribute portable, wireless BCMs in blood banks and district hospitals to meet new clinical audit recommendations. The Association of the British Pharmaceutical Industry (ABPI) identified 11% annual growth in procurement related to BCMs. Moreover, national guidelines now require that all tertiary hospitals utilize a BCM, which increases institutional demand.
Germany is the largest European blood collection monitor market, led by significant healthcare infrastructure investment in automation to ensure optimal management. The federal ministry of health (BMG) is focusing on automating blood collection workflows to push into Germany's National Health Digitalization Strategy. Additionally, regulatory reform that makes obtaining health technology easier via the German Institute of Medical Documentation and Information (DIMDI) helped to facilitate the aforementioned new devices by removing bureaucracy and nuances of new technology within the healthcare system while contributing to competition.
Key Blood Collection Monitor Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
In 2024, the blood collection monitor market is marked by significant global competition. There is an emerging focus on automation, patient safety, and decentralized diagnostics. Leading players in the market are established and use sophisticated systems and processes. Players in the APAC region are developing somewhat less expensive monitors by creating portable blood collection monitors for emerging markets. Companies, including developed and emerging blood collection monitor market companies, are innovating, developing new regional penetration strategies, and exploring pricing and strategy to define a premium price.
|
Company Name |
Country |
Market Share (2024) |
|
Becton, Dickinson & Company |
USA |
~12.2% |
|
Terumo Corporation |
Japan |
~11.5% |
|
Haemonetics Corporation |
USA |
~10.6% |
|
Fresenius Kabi AG |
Germany |
~8.7% |
|
Greiner Bio-One International GmbH |
Austria |
~5.4% |
|
Sarstedt AG & Co. |
Germany |
xx% |
|
Cardinal Health |
USA |
xx% |
|
Nipro Corporation |
Japan |
xx% |
|
Mindray Medical International Ltd. |
China |
xx% |
|
Abbott Laboratories |
USA |
xx% |
|
Thermo Fisher Scientific Inc. |
USA |
xx% |
|
Roche Diagnostics |
Switzerland |
xx% |
|
Siemens Healthineers AG |
Germany |
xx% |
|
Quest Diagnostics |
USA |
xx% |
|
Bio-Rad Laboratories, Inc. |
USA |
xx% |
|
Medtronic plc |
Ireland/USA |
xx% |
|
Qiagen N.V. |
Netherlands |
xx% |
Below are the areas covered for each company in the blood collection monitor market:
Recent Developments
- In December 2024, Becton Dickinson and Babson Diagnostics launched the MiniDraw Capillary Blood Collection System with BetterWay sample prep. This fingertip-based low-volume (<1 mL) collection method allows use by non-phlebotomy personnel in clinics and pharmacies. The model has increased access to diagnostics in unreachable situations.
- In July 2024, Applied Science, Inc. unveiled the HemoFlow 500 blood mixer/scale and the HemoVue cloud-monitoring service. The Community Blood Center of the Ozarks started with 100 units. Thus, this is creating real-time visibility and remote adjustments to their collection workflows
- Report ID: 3992
- Published Date: Jul 22, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Blood Collection Monitor Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
